Mak LY - Search Results

1

Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.

Mak LY, Ko M, To E, Wong DK, Ma JH, Hui TL, Seto WK, Fung J, Lai CL, Yuen MF. Mak LY, et al. J Gastroenterol Hepatol. 2019 Oct;34(10):1817-1823. doi: 10.1111/jgh.14637. Epub 2019 Mar 10. J Gastroenterol Hepatol. 2019. PMID: 30786068

2

DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.

Mak LY, Seto WK, Lai CL, Yuen MF. Mak LY, et al. Expert Opin Drug Saf. 2016;15(3):383-92. doi: 10.1517/14740338.2016.1139573. Epub 2016 Feb 1. Expert Opin Drug Saf. 2016. PMID: 26752687 Review.

3

Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.

Ko MK, Ng SC, Mak LY, Li MK, Lo FH, Ng CK, Lao WC, Tsang S, Chan KH, Hui YT, Shan EH, Loo CK, Hui AJ, To WP, Hung IF, Leung WK. Ko MK, et al. Among authors: mak ly. J Dig Dis. 2016 Sep;17(9):610-617. doi: 10.1111/1751-2980.12397. J Dig Dis. 2016. PMID: 27533786

4

The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infection.

Li J, Mak LY, Wong DK, Fung J, Seto WK, Lai CL, Yuen MF. Li J, et al. Among authors: mak ly. Liver Int. 2017 Sep;37(9):1287-1294. doi: 10.1111/liv.13372. Epub 2017 Feb 10. Liver Int. 2017. PMID: 28111892

5

Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.

Mak LY, Ng SC, Wong IOL, Li MKK, Lo FH, Wong MTL, Leung CM, Tsang SWC, Chan KH, Sze SF, Shan EHS, Lam BCY, Hui AJ, Hung IFN, Leung WK. Mak LY, et al. J Gastroenterol Hepatol. 2018 Jan;33(1):141-149. doi: 10.1111/jgh.13817. J Gastroenterol Hepatol. 2018. PMID: 28475813

6

Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment.

Cheung KS, Seto WK, Wong DK, Mak LY, Lai CL, Yuen MF. Cheung KS, et al. Among authors: mak ly. Oncotarget. 2017 Jul 18;8(29):47507-47517. doi: 10.18632/oncotarget.17670. Oncotarget. 2017. PMID: 28537900 Free PMC article.

7

Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.

Seto WK, Hui RWH, Mak LY, Fung J, Cheung KS, Liu KSH, Wong DK, Lai CL, Yuen MF. Seto WK, et al. Among authors: mak ly. Clin Gastroenterol Hepatol. 2018 Apr;16(4):575-583.e2. doi: 10.1016/j.cgh.2017.09.044. Epub 2017 Sep 29. Clin Gastroenterol Hepatol. 2018. PMID: 28970146

8

Hepatitis B core protein as a therapeutic target.

Mak LY, Wong DK, Seto WK, Lai CL, Yuen MF. Mak LY, et al. Expert Opin Ther Targets. 2017 Dec;21(12):1153-1159. doi: 10.1080/14728222.2017.1397134. Epub 2017 Nov 1. Expert Opin Ther Targets. 2017. PMID: 29065733 Free article. Review.

9

Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels.

Lam YF, Seto WK, Wong D, Cheung KS, Fung J, Mak LY, Yuen J, Chong CK, Lai CL, Yuen MF. Lam YF, et al. Among authors: mak ly. Clin Transl Gastroenterol. 2017 Oct 26;8(10):e125. doi: 10.1038/ctg.2017.51. Clin Transl Gastroenterol. 2017. PMID: 29072673 Free PMC article.

10

Epidemiology and natural history of Wilson's disease in the Chinese: A territory-based study in Hong Kong between 2000 and 2016.

Cheung KS, Seto WK, Fung J, Mak LY, Lai CL, Yuen MF. Cheung KS, et al. Among authors: mak ly. World J Gastroenterol. 2017 Nov 21;23(43):7716-7726. doi: 10.3748/wjg.v23.i43.7716. World J Gastroenterol. 2017. PMID: 29209112 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters